Breast Cancer
Use of efaproxiral in brain metastases from breast cancer improved survival
Published in Women's Health Weekly, February 9th, 2006
According to an article published in the journal Annals of Pharmacotherapy, scientists in the United States conducted a study "to review the mechanism of action and clinical data of efaproxiral use in brain metastases of breast cancer. Articles were identified through MEDLINE (1966-June 2005) and EMBASE (1980-May 2005) searches using the keywords efaproxiral and RSR13."
"Published abstracts over the previous 10 years from various scientific meetings, including American Society of Clinical Oncology and San Antonio Breast Cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Heart Disease
Coronary heart disease is associated with women exposed to ambient particulate matter - Injury Prevention
Female crash test dummy may improve traffic safety protection for women - Ovarian Cancer Prevention
Tea consumption results in a dose-response reduction in risk for ovarian cancer - Rheumatoid Arthritis
Women with rheumatoid arthritis report greater disability in functional capacity than men - Weight Loss
Dietary restrictions appear more beneficial than exercise for weight loss - Allergy & Immunology
Immunoglobulin rBet v1 G4-antibodies may modulate allergic rhinoconjunctivitis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
